Treatment with PCSK9 inhibitors in patients with chronic kidney disease at very high cardiovascular risk by José Manuel Amaro, Florentino Villanego, Javier Naranjo, Cristhian Orellana, Luis Alberto Vigara, Carlos Eduardo Narváez, Julia Torrado, Juan Manuel Cazorla, Claudia Rodríguez, Auxiliadora Mazuecos

Get full text